Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

Published:2018-03-23 Issue:11 Volume:78 Page:2886-2896
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Adelaiye-Ogala Remi,Damayanti Nur P.,Orillion Ashley R.,Arisa Sreevani,Chintala Sreenivasulu,Titus Mark A.,Kao Chinghai,Pili Roberto

Funder

Roswell Park Cancer Institute

Research Facilities Improvement Program

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in nanocarrier-mediated sunitinib delivery: Addressing obstacles and revealing its therapeutic promise in oncological treatment;Journal of Drug Delivery Science and Technology;2024-10

2. TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma;Cancer Research;2024-01-24

3. The influence of sex hormones on renal cell carcinoma;Therapeutic Advances in Medical Oncology;2024-01

4. Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy;Acta Pharmaceutica Sinica B;2023-11

5. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males;Biology of Sex Differences;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP